rs572772837
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP3
The NM_015046.7(SETX):c.3069_3074delTGATGA(p.Asp1023_Asp1024del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,840 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015046.7 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- amyotrophic lateral sclerosis type 4Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- distal hereditary motor neuropathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152174Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 250820 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461666Hom.: 0 AF XY: 0.0000179 AC XY: 13AN XY: 727122 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74338 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: SETX c.3069_3074delTGATGA (p.Asp1023_Asp1024del) results in an in-frame deletion that is predicted to remove two amino acids from the encoded protein. The variant allele was found at a frequency of 2.4e-05 in 250820 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.3069_3074delTGATGA in individuals affected with Amyotrophic Lateral Sclerosis Type 4 and no experimental evidence demonstrating its impact on protein function have been reported. Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2;C1865409:Amyotrophic lateral sclerosis type 4 Uncertain:1
This variant, c.3069_3074del, results in the deletion of 2 amino acid(s) of the SETX protein (p.Asp1023_Asp1024del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs760025407, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SETX-related conditions. ClinVar contains an entry for this variant (Variation ID: 536381). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Amyotrophic lateral sclerosis type 4 Uncertain:1
- -
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 Uncertain:1
- -
not provided Uncertain:1
In-frame deletion of 2 amino acids in a repetitive region with no known function; Has not been previously published as pathogenic or benign to our knowledge -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at